ArticleBMC cancer2012

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in Acute Myeloid Leukaemia.

Mays Jawad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.